Cargando…

Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany

The rising prevalence of vancomycin-resistant enterococci (VRE) is a matter of concern in hospital settings across Europe without a distinct geographical pattern. In this scoping review, we compared the epidemiology of vancomycin-resistant Enterococcus spp. in hospitals in the Netherlands and German...

Descripción completa

Detalles Bibliográficos
Autores principales: Cimen, Cansu, Berends, Matthijs S., Bathoorn, Erik, Lokate, Mariëtte, Voss, Andreas, Friedrich, Alex W., Glasner, Corinna, Hamprecht, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422769/
https://www.ncbi.nlm.nih.gov/pubmed/37568229
http://dx.doi.org/10.1186/s13756-023-01278-0
_version_ 1785089293907132416
author Cimen, Cansu
Berends, Matthijs S.
Bathoorn, Erik
Lokate, Mariëtte
Voss, Andreas
Friedrich, Alex W.
Glasner, Corinna
Hamprecht, Axel
author_facet Cimen, Cansu
Berends, Matthijs S.
Bathoorn, Erik
Lokate, Mariëtte
Voss, Andreas
Friedrich, Alex W.
Glasner, Corinna
Hamprecht, Axel
author_sort Cimen, Cansu
collection PubMed
description The rising prevalence of vancomycin-resistant enterococci (VRE) is a matter of concern in hospital settings across Europe without a distinct geographical pattern. In this scoping review, we compared the epidemiology of vancomycin-resistant Enterococcus spp. in hospitals in the Netherlands and Germany, between 1991 and 2022. We searched PubMed and summarized the national antibiotic resistance surveillance data of the two countries. We included 46 studies and summarized national surveillance data from the NethMap in the Netherlands, the National Antimicrobial Resistance Surveillance database in Germany, and the EARS-Net data. In total, 12 studies were conducted in hospitals in the Netherlands, 32 were conducted in German hospitals, and an additional two studies were conducted in a cross-border setting. The most significant difference between the two countries was that studies in Germany showed an increasing trend in the prevalence of VRE in hospitals, and no such trend was observed in studies in the Netherlands. Furthermore, in both Dutch and German hospitals, it has been revealed that the molecular epidemiology of VREfm has shifted from a predominance of vanA towards vanB over the years. According to national surveillance reports, vancomycin resistance in Enterococcus faecium clinical isolates fluctuates below 1% in Dutch hospitals, whereas it follows an increasing trend in German hospitals (above 20%), as supported by individual studies. This review demonstrates that VRE is more frequently encountered in German than in Dutch hospitals and discusses the underlying factors for the difference in VRE occurrence in these two neighboring countries by comparing differences in healthcare systems, infection prevention control (IPC) guidelines, and antibiotic use in the Netherlands and Germany. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-023-01278-0.
format Online
Article
Text
id pubmed-10422769
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104227692023-08-13 Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany Cimen, Cansu Berends, Matthijs S. Bathoorn, Erik Lokate, Mariëtte Voss, Andreas Friedrich, Alex W. Glasner, Corinna Hamprecht, Axel Antimicrob Resist Infect Control Review The rising prevalence of vancomycin-resistant enterococci (VRE) is a matter of concern in hospital settings across Europe without a distinct geographical pattern. In this scoping review, we compared the epidemiology of vancomycin-resistant Enterococcus spp. in hospitals in the Netherlands and Germany, between 1991 and 2022. We searched PubMed and summarized the national antibiotic resistance surveillance data of the two countries. We included 46 studies and summarized national surveillance data from the NethMap in the Netherlands, the National Antimicrobial Resistance Surveillance database in Germany, and the EARS-Net data. In total, 12 studies were conducted in hospitals in the Netherlands, 32 were conducted in German hospitals, and an additional two studies were conducted in a cross-border setting. The most significant difference between the two countries was that studies in Germany showed an increasing trend in the prevalence of VRE in hospitals, and no such trend was observed in studies in the Netherlands. Furthermore, in both Dutch and German hospitals, it has been revealed that the molecular epidemiology of VREfm has shifted from a predominance of vanA towards vanB over the years. According to national surveillance reports, vancomycin resistance in Enterococcus faecium clinical isolates fluctuates below 1% in Dutch hospitals, whereas it follows an increasing trend in German hospitals (above 20%), as supported by individual studies. This review demonstrates that VRE is more frequently encountered in German than in Dutch hospitals and discusses the underlying factors for the difference in VRE occurrence in these two neighboring countries by comparing differences in healthcare systems, infection prevention control (IPC) guidelines, and antibiotic use in the Netherlands and Germany. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-023-01278-0. BioMed Central 2023-08-12 /pmc/articles/PMC10422769/ /pubmed/37568229 http://dx.doi.org/10.1186/s13756-023-01278-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Cimen, Cansu
Berends, Matthijs S.
Bathoorn, Erik
Lokate, Mariëtte
Voss, Andreas
Friedrich, Alex W.
Glasner, Corinna
Hamprecht, Axel
Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany
title Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany
title_full Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany
title_fullStr Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany
title_full_unstemmed Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany
title_short Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany
title_sort vancomycin-resistant enterococci (vre) in hospital settings across european borders: a scoping review comparing the epidemiology in the netherlands and germany
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422769/
https://www.ncbi.nlm.nih.gov/pubmed/37568229
http://dx.doi.org/10.1186/s13756-023-01278-0
work_keys_str_mv AT cimencansu vancomycinresistantenterococcivreinhospitalsettingsacrosseuropeanbordersascopingreviewcomparingtheepidemiologyinthenetherlandsandgermany
AT berendsmatthijss vancomycinresistantenterococcivreinhospitalsettingsacrosseuropeanbordersascopingreviewcomparingtheepidemiologyinthenetherlandsandgermany
AT bathoornerik vancomycinresistantenterococcivreinhospitalsettingsacrosseuropeanbordersascopingreviewcomparingtheepidemiologyinthenetherlandsandgermany
AT lokatemariette vancomycinresistantenterococcivreinhospitalsettingsacrosseuropeanbordersascopingreviewcomparingtheepidemiologyinthenetherlandsandgermany
AT vossandreas vancomycinresistantenterococcivreinhospitalsettingsacrosseuropeanbordersascopingreviewcomparingtheepidemiologyinthenetherlandsandgermany
AT friedrichalexw vancomycinresistantenterococcivreinhospitalsettingsacrosseuropeanbordersascopingreviewcomparingtheepidemiologyinthenetherlandsandgermany
AT glasnercorinna vancomycinresistantenterococcivreinhospitalsettingsacrosseuropeanbordersascopingreviewcomparingtheepidemiologyinthenetherlandsandgermany
AT hamprechtaxel vancomycinresistantenterococcivreinhospitalsettingsacrosseuropeanbordersascopingreviewcomparingtheepidemiologyinthenetherlandsandgermany